Tag: head of development

CAMBRIDGE, Mass., July 21, 2025 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) today announced upcoming scientific presentations at the 2025 Alzheimer’s Association International Conference (AAIC), taking place July 27-31 in Toronto, Canada. Data on LEQEMBI^® (lecanemab) will include 48-month results from the Clarity AD open-label extension, real-world evidence, and new insights into a subcutaneous formulation for maintenance dosing. Presentations on tau will explore tau-targeted therapies and biomarkers, including baseline characteristics of participants from CELIA, a Phase 2 trial evaluating the efficacy, safety, and tolerability of BIIB080, an investigational antisense oligonucleotide (ASO) therapy that targets tau.

CAMBRIDGE, United Kingdom and MONTREAL, July 10, 2025 (GLOBE NEWSWIRE) -- Epitopea, a transatlantic cancer immunotherapeutics company developing accessible, off-the-shelf RNA-based immunotherapies, today announced the formation of its dedicated clinical team and the expansion of its research team. These developments represent a significant milestone in the company’s ongoing progress in advancing its RNA-based immunotherapies, known as CryptiVax™, into clinical trials.

MONACO, July 07, 2025 (GLOBE NEWSWIRE) -- Exploring the potential of alternative fuels in the maritime sector. During the days of the 12th Monaco Energy Boat Challenge (1-5 July), at the Alternative Fuels Conference on Friday morning, different actors gathered together to discuss technology aspects, challenges, and advancements related to marine energy solutions based on alternative fuels, including hydrogen, methanol, and other innovative sources. Clean hydrogen is still the starting point when it comes to clean energy sources, but now it is time to investigate more to make the next step. As of now, the technology is ready, but it has to be accompanied by infrastructure, investments and supply chain. From an infrastructure point of view, the evolution could be the same as it occurred with oil in the past. “We are looking at the full value chain, a bit like if it was a pipeline. We only provide one piece of the puzzle, but it is a big one. The ecosystem is made of a vessel that will transport, for example, green ammonia from Australia to Korea to Japan in bulk format. Basically, we help owners thanks to our expertise in owning and leasing large floating units,” said Philippe Lavagna, product account manager at SBM Offshore. “We say we need a transition, and it takes time. Miracles don't happen overnight. That's why we are committed to provide clean solutions to the industry,” he added.

Bagsværd, Denmark, 22 June – Today, The New England Journal of Medicine (NEJM) published results from Novo Nordisk’s phase 3 REDEFINE 1 trial evaluating the efficacy and safety of investigational CagriSema plus lifestyle interventions for weight loss in adults with obesity or overweight who have a weight-related medical complication and without diabetes.¹ REDEFINE 1 met its co-primary endpoints and achieved statistically significant and clinically meaningful weight loss at 68 weeks in patients taking CagriSema versus placebo.¹ These data, along with the related phase 3 REDEFINE 2 study conducted in adults with overweight or obesity and type 2 diabetes, were presented today during a scientific symposium at the American Diabetes Association’s (ADA) 85th Scientific Sessions and published in NEJM.

NYU IHIF 2026 Takes Place May 31-June 2 at the Marriott Marquis in New York

The Supervisory Board of Enefit Green has appointed Donatas Celešius as Member of the Management Board and Head of Development at Enefit Green. His three-year term will commence on 7 June 2025.
Celešius has been with Enefit Green since 2018, holding several senior positions, including General Manager and Head of Development for the Lithuanian unit. Prior to joining Enefit Green, he worked on wind energy development at Nelja Energia and led major landfill biogas projects at Proto Paslaugos in Lithuania. 
Celešius holds a master’s degree in information and communication management from Vilnius University and a bachelor’s degree in international business management.